Doxorubicin [17] and PDT-treated cancer cells [18] also upregulate a type I interferon (IFN-1) signaling cascade resulting in C-X-C motif chemokine ligand 10 (CXCL10) secretion and finally in DC maturation. Here, CXCL10 is linked to cancer.